Nigeria’s pharmaceutical companies are ramping up investments and expanding operations to tap growing local opportunities.
Exits of some foreign drug makers and high cost of imported medicines have forced local players to invest in the production of diagnostic kits and devices to address Nigeri
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
